Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03225378
Other study ID # 2017_01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 21, 2017
Est. completion date September 20, 2021

Study information

Verified date October 2021
Source Centre Hospitalier Arras
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The passive leg raising (PLR) test is a reversible preload challenge of around 300 mL of blood that can be repeated as frequently as required without infusing a drop of fluid. Two recent meta-analyses of many studies have confirmed the reliability of the PLR test to predict fluid responsiveness in patients with acute circulatory failure. Nevertheless, the effects of the PLR must be assessed by the direct measurement of cardiac output since changes in arterial pressure do not allow the assessment of the PLR hemodynamic effects with reliability. Moreover, cardiac output must be measured continuously and in real time. In clinical practice, cardiac output measurement can be difficult for different reasons such as the unavailability of the echocardiography machine, or the absence of any continuous cardiac output monitoring technique at the time of acute circulatory failure occurrence. Recently, it was shown that the decrease in pulse pressure variation (PPV) induced by the mini-fluid challenge (100 mL of colloid solution infused in 1 min) was able to predict fluid responsiveness with reliability in patients ventilated with low tidal volume (<8 mL/kg of ideal body weight). Therefore, the investigators hypothesize that the changes in PPV induced by PLR test could be able to predict fluid responsiveness with reliability in mechanically ventilated patients with acute circulatory failure.


Recruitment information / eligibility

Status Completed
Enrollment 286
Est. completion date September 20, 2021
Est. primary completion date September 20, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Mechanically ventilated patients - Patients in whom the physician decides to perform a fluid challenge based on the presence of one of the following criteria: (1) systolic arterial pressure <90 mmHg, mean arterial pressure <65 mmHg, or the need for vasopressor infusion; (2) skin mottling; (3) urine output <0.5 mL/Kg/h for more than or equal to 2 hours; (4) lactate concentrations > 2 mmol/L - Patients in whom the physician decides to perform a PLR test to predict fluid responsiveness - Arterial catheter should be in place for invasive monitoring of arterial pressure and PPV Non inclusion Criteria: - Age <18 yrs - Pregnancy - Moribund patients - Risk of fluid loading induced pulmonary edema - Cardiac arrhythmias - Contraindication to perform PLR (intracranial hypertension, pelvic fractures) Exclusion Criteria : - Changes in vasopressor and sedation agents dosages during the protocol - Changes in ventilatory parameters during the protocol

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Fluid loading of 500 mL of crystalloid solution
Infusion of 500 mL of crystalloid solution in less than 15 minutes
Passive Leg Raising test
This intervention is done before the fluid loading in order to predict fluid responsiveness.

Locations

Country Name City State
France CHU d'Amiens - Réanimation Cardio-Thoracique-Vasculaire Amiens
France CHU d'Amiens - Réanimation chirurgicale Amiens
France Centre Hospitalier d'Arras Arras
France Centre Hospitalier de Béthune Bethune
France CH Boulogne-sur-mer Boulogne-sur-Mer
France CHU de Caen Caen
France Centre Hospitalier de Cambrai Cambrai
France CHU de Dijon Dijon
France Centre Hospitalier de Lens - Anesthésie-Réanimation Lens
France Centre Hospitalier de Lens - Réanimation Lens
France CHRU de Lille - Réanimation Médicale Lille
France CHU de Rouen Rouen

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Arras

Country where clinical trial is conducted

France, 

References & Publications (3)

Cherpanath TG, Hirsch A, Geerts BF, Lagrand WK, Leeflang MM, Schultz MJ, Groeneveld AB. Predicting Fluid Responsiveness by Passive Leg Raising: A Systematic Review and Meta-Analysis of 23 Clinical Trials. Crit Care Med. 2016 May;44(5):981-91. doi: 10.1097 — View Citation

Mallat J, Meddour M, Durville E, Lemyze M, Pepy F, Temime J, Vangrunderbeeck N, Tronchon L, Thevenin D, Tavernier B. Decrease in pulse pressure and stroke volume variations after mini-fluid challenge accurately predicts fluid responsiveness†. Br J Anaesth — View Citation

Monnet X, Marik P, Teboul JL. Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis. Intensive Care Med. 2016 Dec;42(12):1935-1947. doi: 10.1007/s00134-015-4134-1. Epub 2016 Jan 29. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Increase in cardiac output in all mechanically ventilated patients The primary endpoint is the increase in cardiac output of more than or equal to 15% after 500 mL of volume expansion. All included patients are concerned by the primary outcome. Cardiac output will be measured immediately after the end of the volume expansion
Secondary Increase in cardiac output in mechanically ventilated patients with spontaneous breathing activities The secondary endpoint is the increase in cardiac output of more than or equal to 15% after 500 mL of volume expansion. Only patients with spontaneous breathing activities are concerned by this secondary outcome. Cardiac output will be measured immediately after the end of the volume expansion
Secondary Increase in cardiac output in mechanically ventilated patients with low tidal ventilation and/or low respiratory compliance The secondary endpoint is the increase in cardiac output of more than or equal to 15% after 500 mL of volume expansion. Only patients with low tidal ventilation (<8mL/kg of ideal body weight) and/or low respiratory compliance (<30mL/cmH2O) are concerned by this secondary outcome. Cardiac output will be measured immediately after the end of the volume expansion
See also
  Status Clinical Trial Phase
Completed NCT03680963 - Early Versus Differed Arterial Catheterization in Critically Ill Patients With Acute Circulatory Failure: N/A
Terminated NCT01090791 - FLOTRAC/VIGILEO in Acute Circulatory Failure N/A
Completed NCT04337983 - Hemodynamic Characteristics of Patients With SARS-CoV-2
Recruiting NCT04946643 - Subclavian Vein Diameter Variations to Assess Vascular Filling
Recruiting NCT03788772 - Systems Analysis of Antigen Presenting Cells in Human Sepsis N/A
Completed NCT04360304 - Assessment of Agreement Between Two Measurement Methods of Left Ventricular Outflow Tract (LVOT) Velocity Time Integral (VTI) N/A
Completed NCT02050269 - Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study Phase 3
Completed NCT01630577 - Central Venous Pressure Change With Volume Challenge in Patients With Hemodynamic Instability Phase 3
Recruiting NCT05046340 - Applicability of Fluid Responsiveness Indices in Circulatory Failure (AFRIC Study) Study Project
Completed NCT04250389 - Microcirculatory Effects of Methylene Blue
Recruiting NCT05613647 - Concordance Study of Therapeutic Decision-making in Patients With Shock Based on Hemodynamic Monitoring
Completed NCT05847998 - Second Generation DICART Prototype Validation N/A
Not yet recruiting NCT06384287 - Peripheral Tissue Perfusion in Intensive Care
Recruiting NCT02878369 - Evaluation of Doppler Flow From the Femoral Artery as a Reflection of Cardiac Flow in a Vascular Fluid Test N/A
Completed NCT03694717 - Time Course Evolution of Cardiac Output